Amrita Rao1, Katherine Rucinski2, Brooke A Jarrett1, Benjamin Ackerman3, Sara Wallach1, Julia Marcus4,5, Tyler Adamson1, Alex Garner6, Glenn-Milo Santos7,8, Chris Beyrer1, Sean Howell6, Stefan Baral1. 1. Departments of Epidemiology. 2. International Health; and. 3. Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD. 4. Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA. 5. Fenway Institute, Boston, MA. 6. Hornet, San Francisco, CA. 7. Community Health Systems Department, University of California San Francisco, San Francisco, CA; and. 8. Center of Public Health Research, San Francisco Department of Public Health, San Francisco, CA.
Abstract
BACKGROUND: The coronavirus pandemic has necessitated a range of population-based measures to stem the spread of infection. These measures may be associated with disruptions to other health services including for gay, bisexual, and other men who have sex with men (MSM) at risk for or living with HIV. Here, we assess the relationship between stringency of COVID-19 control measures and interruptions to HIV prevention and treatment services for MSM. SETTING: Data for this study were collected between April 16, 2020, and May 24, 2020, as part of a COVID-19 Disparities Survey implemented by the gay social networking app, Hornet. Pandemic control measures were quantified using the Oxford Government Response Tracker Stringency Index: each country received a score (0-100) based on the number and strictness of 9 indicators related to restrictions, closures, and travel bans. METHODS: We used a multilevel mixed-effects generalized linear model with Poisson distribution to assess the association between stringency of pandemic control measures and access to HIV services. RESULTS: A total of 10,654 MSM across 20 countries were included. Thirty-eight percent (3992/10,396) reported perceived interruptions to in-person testing, 55% (5178/9335) interruptions to HIV self-testing, 56% (5171/9173) interruptions to pre-exposure prophylaxis, and 10% (990/9542) interruptions to condom access. For every 10-point increase in stringency, there was a 3% reduction in the prevalence of perceived access to in-person testing (aPR: 0·97, 95% CI: [0·96 to 0·98]), a 6% reduction in access to self-testing (aPR: 0·94, 95% CI: [0·93 to 0·95]), and a 5% reduction in access to pre-exposure prophylaxis (aPR: 0·95, 95% CI: [0·95 to 0·97]). Among those living with HIV, 20% (218/1105) were unable to access their provider; 65% (820/1254) reported being unable to refill their treatment prescription remotely. CONCLUSIONS: More stringent responses were associated with decreased perceived access to services. These results support the need for increasing emphasis on innovative strategies in HIV-related diagnostic, prevention, and treatment services to minimize service interruptions during this and potential future waves of COVID-19 for gay men and other MSM at risk for HIV acquisition and transmission.
BACKGROUND: The coronavirus pandemic has necessitated a range of population-based measures to stem the spread of infection. These measures may be associated with disruptions to other health services including for gay, bisexual, and other men who have sex with men (MSM) at risk for or living with HIV. Here, we assess the relationship between stringency of COVID-19 control measures and interruptions to HIV prevention and treatment services for MSM. SETTING: Data for this study were collected between April 16, 2020, and May 24, 2020, as part of a COVID-19 Disparities Survey implemented by the gay social networking app, Hornet. Pandemic control measures were quantified using the Oxford Government Response Tracker Stringency Index: each country received a score (0-100) based on the number and strictness of 9 indicators related to restrictions, closures, and travel bans. METHODS: We used a multilevel mixed-effects generalized linear model with Poisson distribution to assess the association between stringency of pandemic control measures and access to HIV services. RESULTS: A total of 10,654 MSM across 20 countries were included. Thirty-eight percent (3992/10,396) reported perceived interruptions to in-person testing, 55% (5178/9335) interruptions to HIV self-testing, 56% (5171/9173) interruptions to pre-exposure prophylaxis, and 10% (990/9542) interruptions to condom access. For every 10-point increase in stringency, there was a 3% reduction in the prevalence of perceived access to in-person testing (aPR: 0·97, 95% CI: [0·96 to 0·98]), a 6% reduction in access to self-testing (aPR: 0·94, 95% CI: [0·93 to 0·95]), and a 5% reduction in access to pre-exposure prophylaxis (aPR: 0·95, 95% CI: [0·95 to 0·97]). Among those living with HIV, 20% (218/1105) were unable to access their provider; 65% (820/1254) reported being unable to refill their treatment prescription remotely. CONCLUSIONS: More stringent responses were associated with decreased perceived access to services. These results support the need for increasing emphasis on innovative strategies in HIV-related diagnostic, prevention, and treatment services to minimize service interruptions during this and potential future waves of COVID-19 for gay men and other MSM at risk for HIV acquisition and transmission.
Authors: Joseph G Rosen; Leanne Zhang; Danielle Pelaez; Jenell S Coleman; C To; Lyra Cooper; Praise F Olatunde; Teagan Toomre; Jennifer L Glick; Ju Nyeong Park Journal: AIDS Patient Care STDS Date: 2022-08 Impact factor: 5.944
Authors: Amy Corneli; Brian Perry; Jamilah Taylor; Jeremy Beckford; Nneka Molokwu; Susan Reif; Johnny Wilson; Chelsea Gulden; Jacquelyn Bickham; Julia Siren; Wesley Thompson; Meredith E Clement Journal: AIDS Educ Prev Date: 2022-04
Authors: Christian Grov; Fatima Zohra; Drew A Westmoreland; Chloe Mirzayi; Alexa D'Angelo; Matthew Stief; Sarah Kulkarni; Denis Nash; Adam W Carrico Journal: Arch Sex Behav Date: 2021-11-29
Authors: Kate M Mitchell; Dobromir Dimitrov; Romain Silhol; Lily Geidelberg; Mia Moore; Albert Liu; Chris Beyrer; Kenneth H Mayer; Stefan Baral; Marie-Claude Boily Journal: Lancet HIV Date: 2021-02-19 Impact factor: 16.070
Authors: Catherine R Lesko; Jeanne C Keruly; Richard D Moore; Nicola M Shen; Jarratt D Pytell; Bryan Lau; Anthony T Fojo; Shruti H Mehta; Michele Kipke; Marianna K Baum; Steven Shoptaw; Pamina M Gorbach; Brian Mustanski; Marjan Javanbakht; Suzanne Siminski; Geetanjali Chander Journal: Drug Alcohol Depend Date: 2022-02-12 Impact factor: 4.852